-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Eagle Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2013 to 2022.
- Eagle Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 13.1M shares, a 1.99% increase year-over-year.
- Eagle Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 12.9M shares, a 0.9% decline from 2021.
- Eagle Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 13.1M shares, a 3.19% decline from 2020.
- Eagle Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 13.5M shares, a 1.99% decline from 2019.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)